SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-12-008125
Filing Date
2012-08-10
Accepted
2012-08-10 17:18:17
Documents
5
Period of Report
2012-10-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2210669zpre14a.htm PRE 14A 110910
2 G449652.JPG g449652.jpg GRAPHIC 10538
3 G270297.JPG g270297.jpg GRAPHIC 1927
4 G181232BEI001.GIF g181232bei001.gif GRAPHIC 48780
5 G181232BGI001.GIF g181232bgi001.gif GRAPHIC 54311
  Complete submission text file 0001047469-12-008125.txt   271735
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34637 | Film No.: 121025328
SIC: 2834 Pharmaceutical Preparations